Brookfield Business Holdings

BBUC · TORONTO

$27.81−$0.24 (−0.86%)TodayMarket closed ·
Prev close $28.05

BBUC analyst rating

BuyConsensus of 3 analysts over the last 12 months. 67% rate it a buy.
  • Strong buy0
  • Buy2
  • Hold1
  • Underperform0
  • Sell0

12-month price target · 6 analysts

Average $30.93 (+11.2% upside)

Low
$29.54
Now
$27.81
High
$33.71

Upgrades and downgrades

The latest rating actions, newest first

BBUC analyst upgrades, downgrades and rating actions
FirmDateActionRating
RBC CapitalOct 15, 2026MaintainsOutperform
TD CowenOct 12, 2026MaintainsHold
TD CowenAug 4, 2026MaintainsHold
TD CowenJun 9, 2026InitiatesHold
RBC CapitalMay 11, 2026MaintainsOutperform
ScotiabankMay 11, 2026MaintainsSector Outperform
ScotiabankApr 28, 2026MaintainsSector Outperform

The case for and against

Updated Oct 17, 2026

Bull case

Brookfield Business is supported by a resilient portfolio of industrial and business services assets, with the Industrials segment generating the most revenue and the company’s operational expertise producing strong 19% net IRRs over time. Its outlook is reinforced by active capital recycling, including $1.4B of proceeds over the last 12 months against a ~$2B 24-month target, $335M+ of buybacks since the start of 2025, and a plan to generate $6B+ of recycling proceeds over the next five years. Further upside comes from OpenAI Deployco, which has already identified 500 AI use cases and 150 in use, with expected EBITDA benefits of $150M+, while the stock’s 46% discount to NAV suggests meaningful value remains to be unlocked.

Bear case

Brookfield Business is facing pressure from multiple fundamental weaknesses, including the risk that underlying investments underperform and EV/EBITDA multiples compress by 1x across Industrials, Infrastructure Services, and Business Services. In addition, monetization activity could dry up and the NAV discount could widen to 50%, while Q1/26 EBITDA of US$582MM missed the US$612MM forecast, driven mainly by weaker Infrastructure Services results at Altera and Modulaire. Although Sagen’s Q1/26 loss ratio of 12% was manageable and above 2025 levels, the combination of softer operating performance, limited capital recycling, and valuation compression supports a negative outlook.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.